Patent details

EP2298348 Title: Antibody binding alpha4Beta7 integrin and its use to treat inflammatory bowel disease

Basic Information

Publication number:
EP2298348
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP100109974
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Antibody binding alpha4Beta7 integrin and its use to treat inflammatory bowel disease
French Title of Invention:
Anticorps se liant à l'intégrine alpha4beta7 et ses utilisations pour traiter des maladies intestinales inflammatoires
German Title of Invention:
Antikörper gegen Alpha4beta7 Integrin und sein Verwendung zur Behandlung von Darmerkrankungen
SPC Number:
LUC00014

Dates

Filing date:
13/04/2001
Grant date:
12/10/2016
EP Publication Date:
12/10/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/03/2011
EP B1 Publication Date:
12/10/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
13/04/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/06/2021
 
 

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome, Chuo-ku, 541-0045, Osaka-Shi, Osaka, Japan (JP)

History of Owners

From:
13/04/2001
To:
14/06/2021

Name:
Genentech Inc.
Address:
1 DNA Way, South San Francisco, CA 94080-4990, United States (US)

Name:
Millennium Pharmaceuticals Inc.
Address:
40 Landsdowne Street, Cambridge, MA 02139, United States (US)

Agent

Name:
Dennemeyer & Associates - Validation Department
From:
03/01/2017
Address:
P.O. Box 1502, 1015, Luxembourg, Luxembourg (LU)
To:

Inventor

1

Name:
Fox Judith A.
Address:
United States (US)

2

Name:
Brettman Lee R.
Address:
United States (US)

3

Name:
Allison David Edward
Address:
United States (US)

Priority

1

Priority Number:
550082
Priority Date:
14/04/2000
Priority Country:
United States (US)

2

Priority Number:
748960
Priority Date:
27/12/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/395;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2021/08
Publication date:
01/07/2021
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

Issue number:
201707
Publication date:
15/02/2017
Description:
Document reprinted after correction (B8, B9)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20210000234A
Date Registered:
14/06/2021
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
Dennemeyer & Associates S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome, Chuo-ku, 541-0045, Osaka-Shi, Osaka, Japan (JP)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
27/04/2020
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
Computer Packages INC
Filing date Document type Number of pages
03/01/2017 Incoming Correspondence (Post) 1
14/06/2021 Request For Change 9
14/06/2021 Outgoing Correspondence 1